Exane Derivatives’s PIMCO Strategic Income Fund RCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$25K Hold
4,876
0.01% 355
2022
Q1
$28.7K Sell
4,876
-6,690
-58% -$41.2K 0.01% 630
2021
Q4
$78.5K Sell
11,566
-25,481
-69% -$183K 0.02% 457
2021
Q3
$261K Hold
37,047
0.06% 322
2021
Q2
$281K Buy
37,047
+11,213
+43% +$85.1K 0.06% 303
2021
Q1
$189K Buy
25,834
+10,833
+72% +$77.2K 0.05% 308
2020
Q4
$104K Hold
15,001
0.03% 391
2020
Q3
$96.3K Sell
15,001
-8,000
-35% -$51.4K 0.03% 303
2020
Q2
$147K Sell
23,001
-55,000
-71% -$361K 0.04% 238
2020
Q1
$471K Hold
78,001
0.13% 129
2019
Q4
$707K Hold
78,001
0.13% 125
2019
Q3
$722K Buy
+78,001
New +$748K 0.13% 127

Other funds holding RCS

Exane Derivatives's RCS Position: Q2 2022 in Review

Exane Derivatives held its PIMCO Strategic Income Fund (RCS) position steady in Q2 2022 at 4,876 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #355.

Exane Derivatives first reported a position in RCS in Q3 2019 and has held it in 12 quarters since. The position peaked at $722K in Q3 2019. 55 funds tracked by Wall St. Rank hold RCS as of Q2 2022.

  • Exane Derivatives held 4,876 shares of PIMCO Strategic Income Fund worth $25K as of Q2 2022.
  • Exane Derivatives left its PIMCO Strategic Income Fund share count unchanged in Q2 2022.
  • PIMCO Strategic Income Fund made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #355 holding.
  • Exane Derivatives first reported a position in PIMCO Strategic Income Fund in Q3 2019 and has held it in 12 quarters since.
  • Exane Derivatives's PIMCO Strategic Income Fund position peaked at $722K in Q3 2019.
  • 55 funds tracked by Wall St. Rank held PIMCO Strategic Income Fund as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.